Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

10.1K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
10.1K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.4K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Lineage Commitment01:21

Lineage Commitment

4.6K
Commitment is the  process whereby stem cells:
4.6K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Single-cell DNA methylation analysis uncovers epigenetic pathways in the transformation of MDS to AML.

Leukemia·2026
Same author

[Before the examination: digital check-in].

Radiologie (Heidelberg, Germany)·2026
Same author

ESR1 mutations and CDK4/6 inhibitor choice shape clonal selection and adaptive cell states during acquired resistance.

Genome medicine·2026
Same author

Longitudinal changes in DNA methylation in IDH-mutant glioma fuel disease progression through altered cell state differentiation.

Nature genetics·2026
Same author

Publisher Correction: Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

Nature cancer·2026
Same author

Cell autonomous inflammation in VEXAS is mediated by cGAS-STING.

bioRxiv : the preprint server for biology·2026

Video Experimental Relacionado

Updated: Mar 31, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K

Mutaciones que impulsan la LLC y su evolución en progresión y recaída

Dan A Landau1,2,3,4, Eugen Tausch5, Amaro N Taylor-Weiner1

  • 1Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.

Nature
|October 16, 2015
PubMed
Resumen

Los investigadores identificaron 44 genes mutados y 11 variaciones en el número de copias en la leucemia linfocítica crónica (LLC). Este estudio revela vías clave en el desarrollo y la evolución de la LLC, ofreciendo información sobre la recaída del cáncer y los resultados.

Más Videos Relacionados

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.7K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

846

Videos de Experimentos Relacionados

Last Updated: Mar 31, 2026

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
15:07

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

27.4K
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
09:02

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

22.7K
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

846

Área de la Ciencia:

  • Biología del cáncer
  • La genómica
  • Malignidades hematológicas

Sus antecedentes:

  • Comprender las alteraciones genéticas que impulsan el cáncer es crucial.
  • La patogénesis de la leucemia linfocítica crónica (LLC) requiere una mayor aclaración.
  • La evolución del tumor durante la enfermedad y el tratamiento sigue siendo una cuestión clave.

Objetivo del estudio:

  • Identificar las alteraciones genéticas recurrentes en la LLC.
  • Determinar las vías involucradas en la tumorigénesis de la LLC.
  • Reconstruir la evolución de los eventos del conductor y su impacto en la recaída.

Principales métodos:

  • Secuenciación del exoma entero de 538 CLL y muestras de ADN germinal coincidentes.
  • Análisis de 278 muestras de un estudio clínico prospectivo.
  • Análisis de clonalidad y comparación de muestras de pretratamiento y de recaída.

Principales resultados:

  • Se identificaron 44 genes con mutaciones recurrentes y 11 variaciones en el número de copias somáticas.
  • Se han descubierto nuevos factores de cáncer putativos (por ejemplo, RPS15, IKZF3).
  • Procesamiento / exportación de ARN destacado, actividad MYC y señalización MAPK como vías centrales de CLL.
  • Se ha demostrado una evolución clonal frecuente entre las muestras de pretratamiento y de recaída.

Conclusiones:

  • La secuenciación a gran escala de muestras clínicas ayuda al descubrimiento de nuevos genes de cáncer.
  • Elucidó la red de eventos del conductor en CLL.
  • Proporcionó información sobre el impacto de la evolución clonal en la recaída de la enfermedad y los resultados clínicos.